FDA
-
-
-
-
-
-
-
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19
-
-
-
-
-
-
-
Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week
-
-
-
-
-
-
-
Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Discovery SARS-CoV-2 Kit for the Measurement of the T cell Immune Response to
-
-
-
-
-
-
-
Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent Kit
-
-
-
-
-
-
-
Oxford Immunotec (OXFD) Announces FDA Clearance of the T-SPOT.TB Test for Use in Pediatrics Over the Age of Two
-
-
-
-
-
-
-
Oxford Immunotec Reports Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19
-
322,238 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

